CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Diaxonhit SA Company Snapshot
Diaxonhit SA operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Diaxonhit SA with three other companies in this sector in France: Dbv Technologies (2015 sales of 6.17 million Euro [US$6.62 million] of which 100% was Research & Development), Millet Innovation Sa (21.81 million Euro [US$23.43 million] of which 93% was Pharmacies & Pharmaceutical Wholesale De), and Nicox SA (9.96 million Euro [US$10.70 million] of which 100% was Sale of Pharmaceuticals).

Sales Analysis. During the year ended December of 2015, sales at Diaxonhit SA were 29.46 million Euro (US$31.65 million). This is a decrease of 3.8% versus 2014, when the company's sales were 30.62 million Euro.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Diaxonhit SA
  Stock Performance Chart for Diaxonhit SA
 
  Stock Data: Recent Stock Performance:
  Current Price (3/17/2017): .26
(Figures in Euro)
1 Week 0.0%   13 Weeks 13.0%  
4 Weeks -13.3%   52 Weeks -40.9%  
 
Diaxonhit SA Key Data:
  Ticker: ALEHT Country: France
  Exchanges: PAR Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 29,463,000
(Year Ending Jan 2016).
Employees: 86
  Currency: Euro Market Cap: 20,246,430
  Fiscal Yr Ends: December Shares Outstanding: 77,870,883
  Share Type: Action Ordinaires Closely Held Shares:
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.